These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10834419)

  • 1. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial.
    Lustman PJ; Freedland KE; Griffith LS; Clouse RE
    Diabetes Care; 2000 May; 23(5):618-23. PubMed ID: 10834419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram?
    Khazaie H; Rahimi M; Tatari F; Rezaei M; Najafi F; Tahmasian M
    Neurosciences (Riyadh); 2011 Jan; 16(1):42-5. PubMed ID: 21206443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial.
    Strik JJ; Honig A; Lousberg R; Lousberg AH; Cheriex EC; Tuynman-Qua HG; Kuijpers PM; Wellens HJ; Van Praag HM
    Psychosom Med; 2000; 62(6):783-9. PubMed ID: 11138997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Fluoxetine Collaborative Study Group.
    Small GW; Hamilton SH; Bystritsky A; Meyers BS; Nemeroff CB
    Int Psychogeriatr; 1995; 7 Suppl():41-53. PubMed ID: 8580391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.
    Lustman PJ; Griffith LS; Clouse RE; Freedland KE; Eisen SA; Rubin EH; Carney RM; McGill JB
    Psychosom Med; 1997; 59(3):241-50. PubMed ID: 9178335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
    Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM
    J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine versus placebo in advanced cancer outpatients.
    Alliot C
    J Clin Oncol; 2004 Jan; 22(1):204-5; author reply 206-8. PubMed ID: 14701790
    [No Abstract]   [Full Text] [Related]  

  • 12. Early improvement in HAMD-17 and HAMD-6 scores predicts ultimate response and remission for depressed patients treated with fluoxetine or ECT.
    Lin HS; Lin CH
    J Affect Disord; 2019 Feb; 245():91-97. PubMed ID: 30368075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double-blind clinical trial on analgesic efficacy of fluoxetine for persistent somatoform pain disorder.
    Luo YL; Zhang MY; Wu WY; Li CB; Lu Z; Li QW
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1522-5. PubMed ID: 19733606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study.
    Wiart L; Petit H; Joseph PA; Mazaux JM; Barat M
    Stroke; 2000 Aug; 31(8):1829-32. PubMed ID: 10926942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized double-blind comparison of fluoxetine augmentation by high and low dosage folic acid in patients with depressive episodes.
    Venkatasubramanian R; Kumar CN; Pandey RS
    J Affect Disord; 2013 Sep; 150(2):644-8. PubMed ID: 23507369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial.
    Paile-Hyvärinen M; Wahlbeck K; Eriksson JG
    BMC Fam Pract; 2003 May; 4():7. PubMed ID: 12747810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual mindfulness-based cognitive therapy and cognitive behavior therapy for treating depressive symptoms in patients with diabetes: results of a randomized controlled trial.
    Tovote KA; Fleer J; Snippe E; Peeters AC; Emmelkamp PM; Sanderman R; Links TP; Schroevers MJ
    Diabetes Care; 2014 Sep; 37(9):2427-34. PubMed ID: 24898301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.